Humanetics Executive and Leadership Team

Ahmit s Singhi, the Chief Financial Officer at Humanetics, directs all fiscal planning and capital allocation strategies. Overseeing the financial health of the organization, the Chief Financial Officer ensures alignment with clinical-stage pharmaceutical development goals. This leadership role involves managing investor relations and securing funding for the accelerated discovery of proprietary drugs. By optimizing the balance sheet, Ahmit s Singhi directly impacts the ability of the company to pursue medical countermeasures for radiation modulators. Furthermore, Singhi manages the budgetary requirements for oncology research initiatives across North American markets. Through rigorous oversight of fiscal operations, the Chief Financial Officer maintains the stability necessary for long-term growth. Singhi also coordinates with the board to evaluate the economic feasibility of new drug pipelines. Ultimately, the Chief Financial Officer secures the financial resources required to sustain the mission of addressing unmet medical needs.

Barnaby Loehnis, the President, Humanetics Sensors at Humanetics, directs the manufacturing and operational strategy for high-precision sensor technologies. Overseeing the production facilities, the President, Humanetics Sensors ensures that all hardware components meet the rigorous standards required for medical and industrial applications. This leadership role involves expanding the market reach of sensor products across global industrial sectors. By optimizing supply chain logistics, Barnaby Loehnis directly impacts the operational efficiency of the sensor division. Furthermore, Loehnis manages the engineering teams responsible for developing next-generation sensing solutions that complement the broader pharmaceutical mission. Through the implementation of lean manufacturing processes, the President, Humanetics Sensors reduces waste and improves product quality. Loehnis also coordinates with cross-functional leaders to integrate sensor data into broader diagnostic tools. Ultimately, the President, Humanetics Sensors secures the market position of the company by delivering reliable, high-performance hardware solutions.

Karsten Newbury, the President, Humanetics Digital at Humanetics, leads the strategic expansion of digital service offerings and software-driven solutions. Overseeing the digital business unit, the President, Humanetics Digital ensures that software platforms effectively support the pharmaceutical development lifecycle. This leadership role involves identifying new market opportunities for digital health tools and oncology data management. By fostering innovation in digital product design, Karsten Newbury directly impacts the commercialization strategy for proprietary drugs. Furthermore, Newbury manages the growth of digital operations across international markets, ensuring that software solutions remain compliant with global regulatory standards. Through the alignment of digital initiatives with clinical research objectives, the President, Humanetics Digital enhances the overall value proposition of the company. Newbury also collaborates with the executive team to refine the long-term digital roadmap. Ultimately, the President, Humanetics Digital drives the adoption of advanced technology to solve complex medical challenges.

Barney Loehnis, the President, Humanetics Sensors at Humanetics, manages the strategic development and commercial deployment of specialized sensor systems. Overseeing the technical sales and business development teams, the President, Humanetics Sensors ensures that sensor products reach key industrial and medical markets. This leadership role involves cultivating partnerships with major manufacturers to integrate sensing technology into critical infrastructure. By focusing on market penetration, Barney Loehnis directly impacts the revenue growth of the sensor division. Furthermore, Loehnis oversees the quality assurance protocols for all sensor hardware, ensuring compliance with international safety standards. Through the analysis of market trends, the President, Humanetics Sensors identifies new applications for existing sensor technology, particularly in the context of inflammatory lung disease monitoring. Loehnis also coordinates with the research department to align sensor capabilities with future pharmaceutical needs. Ultimately, the President, Humanetics Sensors drives the commercial success of the hardware portfolio through targeted market engagement.

Sandra Coleman, the Chief Technology Officer, Humanetics Digital at Humanetics, architects the digital infrastructure supporting pharmaceutical research and development. Overseeing the integration of advanced data analytics, the Chief Technology Officer, Humanetics Digital ensures the seamless flow of information across clinical trial platforms. This leadership role involves implementing secure software solutions to accelerate the discovery of proprietary drugs. By leveraging digital tools, Sandra Coleman directly impacts the efficiency of medical countermeasure development. Furthermore, Coleman manages the technical roadmap for inflammatory lung disease research, ensuring that digital systems support complex oncology data requirements. Through the deployment of scalable cloud architectures, the Chief Technology Officer, Humanetics Digital enhances the collaborative capabilities of the research teams. Coleman also evaluates emerging technologies to maintain a competitive edge in the pharmaceutical sector. Ultimately, the Chief Technology Officer, Humanetics Digital drives the digital transformation necessary for modern drug commercialization.